Russell Investments Group Ltd. Sells 7,432 Shares of ICU Medical, Incorporated (NASDAQ:ICUI)

Share on StockTwits

Russell Investments Group Ltd. decreased its position in ICU Medical, Incorporated (NASDAQ:ICUI) by 55.9% during the 2nd quarter, Holdings Channel reports. The firm owned 5,875 shares of the medical instruments supplier’s stock after selling 7,432 shares during the period. Russell Investments Group Ltd.’s holdings in ICU Medical were worth $1,479,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of ICUI. Advisory Services Network LLC grew its holdings in shares of ICU Medical by 70.2% in the second quarter. Advisory Services Network LLC now owns 143 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 59 shares during the last quarter. Huntington National Bank lifted its stake in ICU Medical by 15.3% in the second quarter. Huntington National Bank now owns 474 shares of the medical instruments supplier’s stock worth $119,000 after acquiring an additional 63 shares during the period. ARP Americas LP purchased a new stake in ICU Medical in the first quarter worth $212,000. Qube Research & Technologies Ltd purchased a new stake in ICU Medical in the second quarter worth $233,000. Finally, NumerixS Investment Technologies Inc purchased a new stake in ICU Medical in the first quarter worth $238,000. Hedge funds and other institutional investors own 93.46% of the company’s stock.

ICUI stock traded down $0.20 on Friday, reaching $159.80. The company’s stock had a trading volume of 242,944 shares, compared to its average volume of 221,737. The business has a fifty day simple moving average of $175.00 and a two-hundred day simple moving average of $220.91. ICU Medical, Incorporated has a 12-month low of $151.01 and a 12-month high of $286.45. The firm has a market cap of $3.30 billion, a PE ratio of 20.73 and a beta of 0.93.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.99 EPS for the quarter, topping analysts’ consensus estimates of $1.86 by $0.13. ICU Medical had a return on equity of 12.41% and a net margin of 3.56%. The company had revenue of $312.30 million during the quarter, compared to analyst estimates of $315.47 million. During the same quarter last year, the firm posted $2.69 earnings per share. The firm’s revenue was down 13.4% on a year-over-year basis. On average, equities analysts expect that ICU Medical, Incorporated will post 7.21 EPS for the current year.

A number of brokerages recently commented on ICUI. Zacks Investment Research lowered ICU Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, August 14th. ValuEngine lowered ICU Medical from a “hold” rating to a “sell” rating in a research note on Thursday, August 8th. Raymond James set a $185.00 price target on ICU Medical and gave the stock a “buy” rating in a research note on Friday, September 6th. BidaskClub lowered ICU Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, August 14th. Finally, TheStreet lowered ICU Medical from a “b-” rating to a “c+” rating in a research note on Monday, August 12th. Two analysts have rated the stock with a sell rating, one has given a hold rating and one has assigned a buy rating to the company. ICU Medical presently has a consensus rating of “Hold” and a consensus target price of $233.00.

In other ICU Medical news, CFO Scott E. Lamb sold 25,000 shares of the firm’s stock in a transaction on Wednesday, June 26th. The stock was sold at an average price of $250.00, for a total transaction of $6,250,000.00. Following the completion of the transaction, the chief financial officer now owns 34,984 shares of the company’s stock, valued at $8,746,000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Virginia Ruth Sanzone sold 3,000 shares of the firm’s stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $154.08, for a total value of $462,240.00. Following the transaction, the vice president now directly owns 55 shares of the company’s stock, valued at approximately $8,474.40. The disclosure for this sale can be found here. Insiders have sold 30,317 shares of company stock valued at $7,114,931 in the last three months. Insiders own 11.40% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

See Also: Trade Deficit

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.